씨엔티테크 has completed a successful exit from its portfolio company BARC, achieving a threefold return on investment through its sale to 강남약품, a strategic investor in the healthcare sector.
Information on the Target
씨엔티테크, a prominent player in the investment landscape, has successfully completed the exit of its portfolio company, BARC, a specialist brand in functional recovery footwear, on the 20th of this month. BARC was designed with input from specialists in rehabilitation medicine and is known for its ergonomic recovery shoes that cater to wellness needs and healthcare applications.
Over the years, BARC has strengthened its product competitiveness by catering to the hospital and wellness markets. The brand has made significant strides in developing specialized footwear for healthcare professionals, successfully partnering with major hospitals such as Seoul National University Hospital and Severance Hospital, establishing a strong B2B supply reference.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The recovery footwear industry in South Korea is witnessing significant growth, driven by an increasing demand for ergonomic and wellness-focused products. With a growing awareness around health an
Similar Deals
DKSH → Molecular Diagnostics Korea Inc. (MDxK)
2025
Bambu Ventures → Lemonaid Health
2026
강남약품
invested in
바크(BARC)
in 2023
in a Buyout deal